Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure

1999 ◽  
Vol 96 (6) ◽  
pp. 557 ◽  
Author(s):  
Catherine F. NOTARIUS ◽  
Gary C. BUTLER ◽  
Shin-ichi ANDO ◽  
Michael J. POLLARD ◽  
Beverley L. SENN ◽  
...  
2021 ◽  
Vol 271 ◽  
pp. 03063
Author(s):  
Hu Yuhang

Congestive heart failure (CHF) is a cardiovascular disease associated with the abnormal autonomic nervous system (ANS). Heart rate variability analysis (HRV) is the main method for the quantitative evaluation of autonomic nervous function. Common analytical methods of HRV include time domain, frequency domain, and nonlinear methods. However, these methods generally ignore the short-term volatility of heart rate and autonomic ganglion law. Therefore, this study proposes a new parameter to analyze heart rate variability-determination of a multi-scale order recurrence plot (MSORP_DET). This method can analyze the HRV in patients with heart failure on multiple time scales. This study analyzed the R-R interval in 24-hour HRV data from 98 samples (54 normal subjects and 44 patients with CHF). The results showed that MSORP_DET could significantly distinguish CHF patients from normal subjects (p<0.001). Moreover, the accuracy rate of screening patients with CHF reached the maximum of 81.6% by using the combination of low frequency/high frequency (LF/HF) and MSORP_DET, compared with 78.6% when using LF/HF alone. Therefore, MSORP_DET can be used as a new index to screen patients with CHF and reveal that the rhythm of ANS in patients with heart failure is more complex than that in normal people.


1997 ◽  
Vol 92 (6) ◽  
pp. 543-550 ◽  
Author(s):  
Gary C. Butler ◽  
Shin-Ichi Ando ◽  
John S. Floras

1. There is a substantial non-harmonic or fractal component to the variability of both heart rate and blood pressure in normal subjects. Heart rate is the more complex of these two signals, with respect to the slope, β, of the 1/fβ relationship. In congestive heart failure, heart rate spectral power is attenuated, but the fractal and harmonic components of heart rate and systolic blood pressure variability have not been characterized. 2. Two groups, each comprising 20 men, were studied during 15 min of supine rest and spontaneous respiration: one with functional class II—IV heart failure (age 52 ± 2 years; mean ± SEM) and a second group of healthy men (age 46 ± 2 years). 3. Total spectral power for heart rate was significantly reduced in heart failure (P < 0.02), whereas total spectral power for systolic blood pressure was similar in the two groups. In both heart failure and normal subjects, 65–80% of total spectral power in these two signals displayed fractal characteristics. 4. In heart failure, the slope of the 1/fβ relationship for heart rate was significantly steeper than in normal subjects (1.40 ± 0.08 compared with 1.14 ± 0.05; P < 0.05), indicating reduced complexity of the fractal component of heart rate variability. There was no significant difference in the 1/fβ slope for systolic blood pressure variability between these two groups, but the blood pressure signals were less complex than heart rate variations in both heart failure (2.31 ± 0.15; P < 0.006) and normal subjects (2.47 ± 0.15; P < 0.0001). 5. Parasympathetic nervous system activity, as estimated from heart rate variability was reduced (P < 0.01) in patients with heart failure, whereas trends towards increased sympathetic nervous system activity and decreased non-harmonic power were not significant. 6. The non-harmonic components of cardiac frequency are reduced in heart failure. Non-harmonic power is not attenuated, but the complexity of the heart rate signal is less than in subjects with normal ventricular function. A reduction in parasympathetic modulation appears to contribute to this loss of complexity of heart rate. Consequently, the heart rate signal comes to resemble that of blood pressure. In contrast, the variability and complexity of the systolic blood pressure signal is similar in heart failure and normal subjects. This reduced complexity of heart rate variability may have adverse implications for patients with heart failure.


2008 ◽  
Vol 114 (3) ◽  
pp. 243-249 ◽  
Author(s):  
Matthew P. Gilman ◽  
John S. Floras ◽  
Kengo Usui ◽  
Yasuyuki Kaneko ◽  
Richard S. T. Leung ◽  
...  

Patients with heart failure or OSA (obstructive sleep apnoea) have reduced HF-HRV (high-frequency heart rate variability), indicating reduced cardiac vagal modulation, a marker of poor prognosis. CPAP (continuous positive airway pressure) abolishes OSA in patients with heart failure, but effects on daytime HF-HRV have not been determined. We hypothesized that, in patients with heart failure, treatment of coexisting OSA by CPAP would increase morning HF-HRV. In 19 patients with heart failure (left ventricular ejection fraction <45%) and OSA (≥20 apnoeas and hypopnoeas/h of sleep), HF-HRV was quantified before and 1 month after randomization to a control or CPAP-treated group. In the control group (n=7), there were no changes in HF-HRV over the 1 month study during wakefulness in the morning. In the CPAP-treated group (n=12) HF-HRV increased significantly during wakefulness in the morning [from 2.43±0.55 to 2.82±0.50 log(ms2/Hz); P=0.002] due to an increase in transfer function between changes in lung volume and changes in HF-HRV (92.37±96.03 to 219.07±177.14 ms/l; P=0.01). In conclusion, treatment of coexisting OSA by nocturnal CPAP in patients with heart failure increases HF-HRV during morning wakefulness, indicating improved vagal modulation of heart rate. This may contribute to improved prognosis.


PLoS ONE ◽  
2016 ◽  
Vol 11 (12) ◽  
pp. e0167407 ◽  
Author(s):  
Lays Magalhães Braga ◽  
Gustavo Faibischew Prado ◽  
Iracema Ioco Kikuchi Umeda ◽  
Tatiana Satie Kawauchi ◽  
Adriana Marques Fróes Taboada ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document